Vaccine efficacy or effectiveness from attack rates in vaccinated and unvaccinated people

Measures the proportionate reduction in risk among vaccinated people as 1 minus the ratio of the attack rate among the vaccinated to the attack rate among the unvaccinated. The same quantity is the risk difference divided by the attack rate among the unvaccinated. It is called efficacy when measured in a trial under ideal conditions and effectiveness when measured under field conditions.

Signature

VE = 1 - AR_v / AR_u
Inputs
InputsDefinitionUnit
AR_vAttack rate among vaccinated people over the periodproportion
AR_uAttack rate among unvaccinated people over the same period, greater than zeroproportion
Output
VEProportionate reduction in risk among vaccinated people, efficacy in a trial or effectiveness in field conditionsproportion, often reported as a percentage

Function

Attack rate, secondary attack rate and final epidemic size function

Maps counts of new cases and of people at risk over a stated period to an attack rate, a risk expressed as a proportion rather than a rate per unit of time. The same structure gives the secondary attack rate among contacts of primary cases, and comparing attack rates between groups gives the attack rate ratio and vaccine efficacy or effectiveness. Under the assumptions of the simple susceptible, infectious and recovered model, the final attack rate of a completed epidemic is linked to the basic reproduction number R_0 through the final size relation. In an economic evaluation the attack rate is either a fixed input probability of infection, as in a static model, or an output that changes with the intervention, as in a dynamic transmission model.

Try this function

Implementations

  • Excel

    Vaccine effectiveness from two named attack rates

    Excel subtracts the ratio of the vaccinated to the unvaccinated attack rate from 1, using named cells.

    =1-AttackRateVaccinated/AttackRateUnvaccinated

Assumptions

  • Comparison groups decide which vaccine effect is measured

    Halloran and colleagues show that the choice of comparison groups decides whether 1 minus the risk ratio estimates the effect of vaccination on an individual or the indirect, total or overall effects of a programme. The groups are stated before the estimate is used as the vaccine effect in a cost-effectiveness model.

  • Same case definition and period for vaccinated and unvaccinated attack rates

    Both attack rates are counted over the same period with the same case definition and ascertainment, so the ratio is not distorted by differences in counting.

Worked examples

  • Varicella vaccine effectiveness in the CDC school outbreak

    In the CDC example of a 2002 varicella outbreak in Oregon, 18 of 152 vaccinated and 3 of 7 unvaccinated children developed varicella, attack rates of about 0.1184 and 0.4286. The vaccine effectiveness is about 0.724, which the CDC text reports as 72%.

    AR_v = 0.1184; AR_u = 0.4286; VE = 0.724

Common errors

  • Using the whole-population attack rate as the comparator for vaccine effectiveness

    Dividing by the attack rate among all children in the CDC varicella example, about 0.1321, rather than among the unvaccinated gives a vaccine effectiveness of about 0.104 instead of 0.724.

  • Counting only infections averted among the vaccinated in a programme evaluation

    Applying the vaccine effect with a fixed attack rate counts only infections averted among vaccinated people. In the article's illustrative example with R_0 of 2 and 30% coverage, that gives 23,910 of the 43,900 infections averted, about 54%, because reduced transmission also lowers the attack rate among the unvaccinated.

Sources

  • CDC vaccine efficacy and effectiveness from attack rates

    Centers for Disease Control and Prevention. Principles of Epidemiology in Public Health Practice. 3rd ed. Atlanta: CDC; 2006, page last reviewed 2012. Lesson 3: Measures of Risk, section 6: Measures of public health impact. Vaccine efficacy and effectiveness as the proportionate reduction in risk among vaccinated people, the formula as 1 minus the risk ratio or as the risk difference over the risk among the unvaccinated, and the varicella example.

    View source →

  • Comparison groups for direct, indirect, total and overall vaccine effects

    Halloran ME, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American Journal of Epidemiology. 1997;146(10):789-803. Vaccine efficacy and effectiveness measured as 1 minus a relative risk, and the framework relating the choice of comparison groups to direct, indirect, total and overall effects.

    View source →

Canonical Identity